Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent reform passes House

This article was originally published in The Gray Sheet

Executive Summary

Patent reform act (H.R. 1908) passes House Sept. 7 by a vote of 220-175. Device stakeholders are concerned that the bill limits the factors judges may consider when awarding damages for infringement, giving too much weight to the value of the individual patent instead of the entire product. The Bush administration opposes the bill as long as the so-called "apportionment" language remains. The House passed five amendments, including one offered by John Conyers, D-Mich., which among other revisions seeks to clarify that apportionment is not mandatory and other criteria may be considered. Another amendment requires the Patent Office to study over the next year trends in how damages have been awarded in recent court cases. The Senate has yet to vote on its version of the legislation, S. 1145 (1"The Gray Sheet" July 23, 2007, p. 19)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel